Building a Resilient and Equitable Health System in South Africa

By Crystal Lubbe

November 7, 2024

The article titled “DTIC Calls for a Resilient Health System” on the SAnews website highlights the critical need for a resilient health system in South Africa, as emphasised by Deputy Minister of Trade, Industry and Competition, Zuko Godlimpi. He outlines several key points regarding the importance of establishing a robust health system capable of facing various challenges.

Call for a Resilient Health System

Deputy Minister Zuko Godlimpi has made it clear that building a resilient health system is a top priority. He highlighted that this system must be robust enough to withstand healthcare challenges that may arise in the future.

Equitable Access

Deputy Minister stressed the need for equitable access to healthcare. It is vital that all segments of the population have fair and equal opportunities to receive health services, minimizing disparities in healthcare access.

Priorities

The call for a robust healthcare framework includes focusing on several key areas:
Equitable Access: Ensuring that healthcare services are accessible to everyone, especially disadvantaged communities.
Human Resources: Enhancing the development of human resources within the healthcare sector to build a stronger workforce.
Infrastructure and Resources: Upgrading healthcare infrastructure and ensuring access to essential medicines, vaccines, and other health products.
Private Sector Engagement: Engaging the private sector to play an active role in strengthening the health system.

Broader Context

This initiative is part of a broader effort to improve the health system in South Africa. It aligns with the Presidential Health Compact, which aims to strengthen the overall health system, enhance access to healthcare, and prepare for the implementation of the National Health Insurance. Through these measures, the goal remains clear: to build a health system that serves all South Africans effectively.

Reference url

Recent Posts

Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities for Innovation and A...

By HEOR Staff Writer

January 5, 2026

Political Agreement Marks Shift in EU Pharmaceutical Legislation The European Medicines Agency (EMA) Management Board meeting in December 2025 highlighted the political agreement on new EU pharm...
Strategic Avalere Health Appointments Enhance Leadership in Navigating US Healthcare Policy Changes

By João L. Carapinha

December 17, 2025

Avalere Health strengthened its appointments, with Matt Kazan returning as Senior Vice President of Policy, where he previously served as a former top advisor on the US Senate Committee on Finance, and he will now lead the policy team amid changes like the Inflation Reduction Act. Laura Housman, ...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggressive Prostate Cancer

By HEOR Staff Writer

December 16, 2025

AKEEGA BRCA2 Approval Ushers in Precision Era for mCSPC The AKEEGA BRCA2 approval by the U.S. Food and Drug Administration (FDA) on December 12, 2025, represents a breakthrough for patients with BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC). Johnson & Johnson...